A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects

NCT04973189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: SHR-1707
DRUG: Placebo
DRUG: SHR-1707
DRUG: Placebo

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.